Group Leader - ADME
Broad Institute, Massachusetts, United States
Ritu Singh is a Group Leader of the ADME team within the Center for the Development of Therapeutics (CDoT) at the Broad Institute of MIT and Harvard. Her group provides analytical and ADME (absorption, distribution, metabolism, excretion) testing capabilities to support discovery and development of small molecules in multiple therapeutic projects. She has a wide range of expertise in the areas of drug metabolism, metabolite identification, drug-drug interaction, transporters, and bio-analysis using liquid chromatography-mass spectrometry.
Prior to joining the Broad Institute in September 2018, Singh worked as a staff scientist and study director at Corning Life Sciences in Woburn, Massachusetts. She had previously worked in industry at Synta Pharmaceuticals, Cyprotex, Merial, and Merck.
Singh holds a Ph.D. from Rutgers University, an M.Pharm. from Bombay University, Mumbai, India, and a B.Pharm. from Shreemati Nathibai Damodar Thackersey Women’s University, Mumbai, India.
Disclosure information not submitted.
Tuesday, February 8, 2022
3:00 PM – 4:00 PM